Yanbing Wang

Yanbing Wang

Auto-generated profile, based on publicly available information

Yanbing Wang

Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, People’s Republic of China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Pharmacological Research
Verified
Journal Article
Closed access
PLPinyi Liu
Pinyi Liu
YWYanbing Wang
Yanbing Wang
GYGe Yang
Ge Yang
QZQihe Zhang
Qihe Zhang
LMLingbin Meng
Lingbin Meng
Xin JiangXin Jiang
Xin Jiang

1 January 2020 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
ZWZhonghan Wang
Zhonghan Wang
HLHe Liu
He Liu
WLWenbin Luo
Wenbin Luo
TCTianyang Cai
Tianyang Cai
ZLZuhao Li
Zuhao Li
XYXiaoyu Yang
Xiaoyu Yang
Natural biomaterials, such as collagen, gelatin, and chitosan, are considered as promising candidates for use in tissue regeneration treatment, given their similarity to natural tissues regarding components and structure. Nevertheless, only receiving a crosslinking process can these biomaterials exhibit sufficient strength to bear high tensile loads for use in skeletal system regeneration. Recently, genipin, a natural chemical compound extracted from gardenia fruits, has shown great potential as a reliable crosslinking reagent, which can reconcile the crosslinking effect and biosafety profile simultaneously. In this review, we briefly summarize the genipin extraction process, biosafety, and crosslinking mechanism. Subsequently, the applications of genipin regarding aiding skeletal system regeneration are discussed in detail, including the advances and technological strategies for reconstructing cartilage, bone, intervertebral disc, tendon, and skeletal muscle tissues. Finally, based on the specific pharmacological functions of genipin, its potential applications, such as its use in bioprinting and serving as an antioxidant and anti-tumor agent, and the challenges of genipin in the clinical applications in skeletal system regeneration are also presented.

15 November 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
SLShaorong Li
Shaorong Li
YCYutao Cui
Yutao Cui
HLHe Liu
He Liu
YTYuhang Tian
Yuhang Tian
GWGan Wang
Gan Wang
YWYanbing Wang
Yanbing Wang
In recent years, the research of metal ions has become more extensive in bone tissue engineering. We review the mechanism and application of metal ions in the treatment of different pathological types of bone defects in bone tissue engineering.

4 January 2024 in Materials Today Bio
Verified
Journal Article
Open access
SLShaorong Li
Shaorong Li
YCYutao Cui
Yutao Cui
HLHe Liu
He Liu
YTYuhang Tian
Yuhang Tian
YFYi Fan
Yi Fan
YWYanbing Wang
Yanbing Wang
The treatment of bone defects is a difficult problem in orthopedics. The excessive destruction of local bone tissue at defect sites destroys blood supply and renders bone regeneration insufficient, which further leads to delayed union or even nonunion. To solve this problem, in this study, we incorporated icariin into alginate/mineralized collagen (AMC) hydrogel and then placed the drug-loaded hydrogel into the pores of a 3D-printed porous titanium alloy (AMCI/PTi) scaffold to prepare a bioactive scaffold with the dual functions of promoting angiogenesis and bone regeneration. The experimental results showed that the ACMI/PTi scaffold had suitable mechanical properties, sustained drug release function, and excellent biocompatibility. The released icariin and mineralized collagen (MC) synergistically promoted angiogenesis and osteogenic differentiation in vitro. After implantation into a rabbit radius defect, the composite scaffold showed a satisfactory effect in promoting bone repair. Therefore, this composite dual-functional scaffold could meet the requirements of bone defect treatment and provide a promising strategy for the repair of large segmental bone defects in clinic.

1 November 2017 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
XZXin Zhao
Xin Zhao
YYYukai Yang
Yukai Yang
JXJianting Xu
Jianting Xu
YLYang Luo
Yang Luo
YXYing Xin
Ying Xin
YWYanbing Wang
Yanbing Wang
The purpose of the present study was to examine the function of microRNA-95-3p on cell growth of osteosarcoma and to investigate its mechanism. Compared to healthy controls, the serum expression of microRNA-95-3p was effectively upregulated in patients with osteosarcoma. MicroRNA-95-3p expression in patients with osteosarcoma had significant association with clinical stage. Downregulation of microRNA-95-3p expression suppressed cell growth, induced apoptosis, increased caspase-3 and caspase-9 activities and Bax/Bcl-2 protein expression in osteosarcoma cells. The anticancer effects of microRNA-95-3p on cell growth of osteosarcoma cell suppressed TGF-β and p-Smad2 protein expression, induced p21 protein expression and suppressed cyclin D1 protein expression in osteosarcoma cells. Whereas, overexpression of microRNA-95-3p increased cell growth, and inhibited apoptosis of osteosarcoma cells through TGF-β/CDKN1A/p21/cyclin D1 expression. After promotion of TGF-β, the anticancer effects of microRNA-95-3p were effectively reversed in osteosarcoma cells. Taken together, our results demonstrate that downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression.

20 November 2018 in Journal of Bionic Engineering
Verified
Journal Article
Closed access
PDF file
XZXin Zhao
Xin Zhao
JXJianlin Xiao
Jianlin Xiao
YSYu Sun
Yu Sun
ZZZhe Zhu
Zhe Zhu
MXMeng Xu
Meng Xu
JWJincheng Wang
Jincheng Wang